Extra Strength Pain Aid

Product NDC: 69732-006
11-digit product format: 697320006
Labeler code: 69732
Product ID: 69732-006_55f8f0e5-bdb4-ceb0-e063-6294a90a6246
Type: HUMAN OTC DRUG
Nonproprietary name: Acetaminophen, Aspirin, Caffeine
Dosage form: TABLET
Route: ORAL
Labeler: Hi-Tech Nutaceuticals, LLC
Application: M013
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2020-04-30
Substance: CAFFEINE; ACETAMINOPHEN; ASPIRIN
Active strength: 65; 250; 250 mg/1; mg/1; mg/1
Pharmacologic classes: Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	69732-006-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	69732-006-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	69732-006-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	69732-006-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	69732-006-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	69732-006-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	69732-006-01	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	69732-006-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	69732-006-01	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	69732-006-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	69732-006-01	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	69732-006-01	`557ba5c1ecfa…`	`9c80585c8c6e…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Extra Strength Pain Aid
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
CAFFEINE	65 mg/1
ACETAMINOPHEN	250 mg/1
ASPIRIN	250 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
3G6A5W338E	Internal UNII lookup
362O9ITL9D	Internal UNII lookup
R16CO5Y76E	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
308297	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
a39e4b99-700d-0f5c-e053-2a95a90a6bd3	Available on FDA.report

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
69732-006-01	2024-01-30	C162847	48780-1	1030e365-16bc-111a-e063-dadaa90a10e2	Extra Strength Pain Aid

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 27 of 79 · 1,579 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Acetaminophen Diphenhydramine HCL	ACETAMINOPHEN DIPHENHYDRAMINE HCL	WALGREENS CO.	d92d97a8-0ee3-1206-e053-2a95a90a72a8	2025-12-19	Warnings	Exact identifier application number: M013
Acetaminophen	ACETAMINOPHEN	SAM'S WEST INC	0c8e7095-0806-4501-e063-6394a90a89aa	2025-12-19	Warnings	Exact identifier application number: M013
Acetaminophen Diphenhydramine HCL	ACETAMINOPHEN DIPHENHYDRAMINE HCL	WALGREEN CO.	b3763182-2428-155a-e053-2995a90ab578	2025-12-19	Warnings	Exact identifier application number: M013
Acetaminophen	ACETAMINOPHEN	WALGREENS	e467b78e-9f23-5563-e053-2a95a90a586e	2025-12-19	Warnings	Exact identifier application number: M013
Acetaminophen Diphenhydramine HCL	ACETAMINOPHEN DIPHENHYDRAMINE HCL	Walgreens	fd7c3250-35d4-494a-e053-6394a90a2db5	2025-12-19	Warnings	Exact identifier application number: M013
Acetaminophen	ACETAMINOPHEN	CVS PHARMACY, INC	1ddb8a2b-3081-3eda-e063-6294a90ab82b	2025-12-19	Warnings	Exact identifier application number: M013
Acetaminophen	ACETAMINOPHEN	CVS PHARMACY, INC	b1307d52-10e6-46e1-e053-2995a90a03b6	2025-12-19	Warnings	Exact identifier application number: M013
Acetaminophen	ACETAMINOPHEN	CVS PHARMACY, INC	c2c6d6a1-b492-506d-e053-2995a90aac23	2025-12-19	Warnings	Exact identifier application number: M013
Acetaminophen	ACETAMINOPHEN	FAMILY DOLLAR	f8383108-0970-9f1e-e053-6294a90ad38f	2025-12-19	Warnings	Exact identifier application number: M013
ACETAMINOPHEN 500 MG	ACETAMINOPHEN	NUVICARE LLC	591ee107-e953-4982-b75f-13a0afd7c4ae	2025-12-19	Warnings	Exact identifier application number: M013
Nuvicare Headache Relief	ACETAMINOPHEN, ASPIRIN, CAFFEINE	NUVICARE LLC	3ede0fb6-c089-4253-9878-2b01c39e9c87	2025-12-19	Warnings	Exact identifier application number: M013
Aspirin Low Dose	ASPIRIN	NUVICARE LLC	3a4aa3c7-b726-4303-8803-74196fa5637a	2025-12-19	Warnings	Exact identifier application number: M013
ACETAMINOPHEN 500 MG	ACETAMINOPHEN	NUVICARE LLC	95edf7bd-b6a7-4be5-9ad7-8748e7c2d06e	2025-12-19	Warnings	Exact identifier application number: M013
Pain Relief PM	ACETAMINOPHEN, DIPHENHYDRAMINE	NUVICARE LLC	32a5611b-9bf6-4850-a7ff-fa240da04f45	2025-12-19	Warnings	Exact identifier application number: M013
Acetaminophen	ACETAMINOPHEN	BETTER LIVING BRANDS LLC.	ac0e96d0-746e-fb42-e053-2a95a90a1957	2025-12-18	Warnings	Exact identifier application number: M013
Acetaminophen	ACETAMINOPHEN	BETTER LIVING BRANDS LLC.	ac0e5dc0-96eb-47b2-e053-2995a90add0e	2025-12-18	Warnings	Exact identifier application number: M013
Acetaminophen Diphenhydramine HCl	ACETAMINOPHEN DIPHENHYDRAMINE HCL	BETTER LIVING BRANDS LLC.	ac0f8d5c-d200-1156-e053-2a95a90aece6	2025-12-18	Warnings	Exact identifier application number: M013
Pain and Fever Childrens	ACETAMINOPHEN	CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED	e55645ab-66f9-4160-8247-395bc5b02711	2025-12-18	Warnings	Exact identifier application number: M013
Dolex Forte	ACETAMINOPHEN, ASPIRIN, CAFFEINE	Pharmadel LLC	3c2d90fc-130d-476c-e063-6294a90a8c15	2025-12-17	Warnings	Exact identifier application number: M013
CareOne Childrens Acetaminophen	ACETAMINOPHEN	American Sales Company	07bc6632-fabb-427d-81f3-c27c54caa6a0	2025-12-17	Warnings	Exact identifier application number: M013

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
3G6A5W338E	CAFFEINE	58-08-2	CAFFEINE
362O9ITL9D	ACETAMINOPHEN	103-90-2	ACETAMINOPHEN
R16CO5Y76E	ASPIRIN	50-78-2	ASPIRIN

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
69732-006-01	69732000601	30 TABLET in 1 BOTTLE, PLASTIC (69732-006-01)	30 tablet	2020-04-30	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Extra Strength Pain Aid	Hi-Tech Nutaceuticals, LLC \| Hi-Tech Nutraceuticals, LLC \| Hi-Tech Nuraceuticals, LLC	2026-07-06	HUMAN OTC DRUG LABEL	6